219 related articles for article (PubMed ID: 19803732)
1. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.
Rodriguez CO; Crabbs TA; Wilson DW; Cannan VA; Skorupski KA; Gordon N; Koshkina N; Kleinerman E; Anderson PM
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):197-206. PubMed ID: 19803732
[TBL] [Abstract][Full Text] [Related]
2. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
Gordon N; Kleinerman ES
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
[TBL] [Abstract][Full Text] [Related]
3. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
[TBL] [Abstract][Full Text] [Related]
4. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
Koshkina NV; Kleinerman ES
Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
[TBL] [Abstract][Full Text] [Related]
5. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
Huang G; Nishimoto K; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
[TBL] [Abstract][Full Text] [Related]
6. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
Gordon N; Kleinerman ES
Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
[TBL] [Abstract][Full Text] [Related]
7. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
8. Eradication of osteosarcoma lung metastasis using intranasal gemcitabine.
Jia SF; Worth LL; Turan M; Duan Xp XP; Kleinerman ES
Anticancer Drugs; 2002 Feb; 13(2):155-61. PubMed ID: 11901308
[TBL] [Abstract][Full Text] [Related]
9. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
10. Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks?
Rodriguez CO
Adv Exp Med Biol; 2014; 804():237-56. PubMed ID: 24924178
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.
Ando T; Ichikawa J; Okamoto A; Tasaka K; Nakao A; Hamada Y
J Orthop Res; 2005 Jul; 23(4):964-9. PubMed ID: 16023013
[TBL] [Abstract][Full Text] [Related]
12. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Xu J; Guo W; Xie L
BMC Cancer; 2018 Oct; 18(1):987. PubMed ID: 30326879
[TBL] [Abstract][Full Text] [Related]
13. Autophagy in osteosarcoma.
O'Farrill JS; Gordon N
Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine for the treatment of patients with osteosarcoma.
Wei MY; Zhuang YF; Wang WM
Asian Pac J Cancer Prev; 2014; 15(17):7159-62. PubMed ID: 25227807
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).
Martin-Broto J; Redondo A; Valverde C; Vaz MA; Mora J; Garcia Del Muro X; Gutierrez A; Tous C; Carnero A; Marcilla D; Carranza A; Sancho P; Martinez-Trufero J; Diaz-Beveridge R; Cruz J; Encinas V; Taron M; Moura DS; Luna P; Hindi N; Lopez-Pousa A
Ann Oncol; 2017 Dec; 28(12):2994-2999. PubMed ID: 29045512
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized Chemotherapy for Osteosarcoma.
Gordon N; Felix K; Daw NC
Adv Exp Med Biol; 2020; 1257():67-73. PubMed ID: 32483731
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB.
Zhang B; Shi ZL; Liu B; Yan XB; Feng J; Tao HM
Anticancer Drugs; 2010 Mar; 21(3):288-96. PubMed ID: 20038829
[TBL] [Abstract][Full Text] [Related]
20. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]